A COCKTAIL of drugs targeting breast cancer could double the amount of time patients live without the disease progressing.
Researchers have branded the breakthrough as potentially transformative for those with a common form of advanced, aggressive breast cancer.
Some 325 patients from 28 countries took part in a drug trial. More than half had cancer that had spread to three or more organs, while over 80% had hemotherapy.
A total of 161 patients were given the three-drug therapy, which comprised two targeted drugs palbociclib, a type of cancer growth blocker, and a new drug called inavolisib.
この記事は Daily Mirror UK の October 31, 2024 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Daily Mirror UK の October 31, 2024 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
YOUNG: NEVER SAY DIE
Veteran Ashley says spirit at Goodison is pushing them up Prem table
NEW KIDS ON THE BLOCK
Livingstone backs his side loaded with 'untapped talent' to crush it in Caribbean
THE BOY'S DOM GOOD!
Winger Young loving life after taking a risk to swap the UK for Oz
it's We'll never see her grow...just devastating
Inquest hears from dad of Emily, 15, killed in speedboat horror
BLAZE AT NUKE SUB SHIPYARD
Two workers treated in hospital
My 250 'babies'
Sylvia shows off her brood of realistic-looking reborn dolls
GEORDIE? SURE
Uni to celebrate accent at open day
Breast cancer drug hope
Therapy slows disease's progression
Tragedy of 90ft tower block fall
Pregnant woman died after flat plunge as 'miracle' baby survives
'Devastated' not to be a British agent
Ex-soldier 'a patriot', trial told
